West Pharmaceutical Services WST EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's EPS (diluted)?
- West Pharmaceutical Services (WST) reported EPS (diluted) of $1.92 in Q1 2026.
- How has West Pharmaceutical Services's EPS (diluted) changed year-over-year?
- West Pharmaceutical Services's EPS (diluted) increased by 56.1% year-over-year, from $1.23 to $1.92.
- What is the long-term trend for West Pharmaceutical Services's EPS (diluted)?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's EPS (diluted) has grown at a -5.9% compound annual growth rate (CAGR), from $8.66 to $6.79.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.